ITEMS IN AFP WITH KEYWORD:
Premenstrual syndrome is defined as recurrent moderate psychological and physical symptoms that occur during the luteal phase of menses and resolve with menstruation. It affects 20 to 32 percent of premenopausal women. Women with premenstrual dysphoric disorder experience affective or somatic sympto...
The American Psychiatric Association (APA) recently updated its guideline on the treatment of major depressive disorder. The new evidence-based guideline summarizes recommendations on the use of antidepressants and other drug therapies; psychotherapy, including cognitive behavior therapy; and electroconvulsive therapy (ECT).
There are no studies that have shown any antidepressant to be absolutely safe for use during any stage of pregnancy. The use of selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) during pregnancy does not increase the risk of congenital malformations or miscarriage.
Oct 15, 2010 Issue
Screening for Depression in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for depression when staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and follow-up.
In 2009, the U.S. Preventive Services Task Force (USPSTF) reaffirmed its support for screening for depression in adults, and expanded on its caveat that screening is effective only if support systems are in place for appropriate treatment of patients with positive screening results.
Postpartum major depression is a disorder that is often unrecognized and must be distinguished from “baby blues.” Antenatal depressive symptoms, a history of major depressive disorder, or previous postpartum major depression significantly increase the risk of postpartum major depression. Screening...
Case study: C.J. is a 54-year-old man who presents with a request to refill his antihypertensive medication. He reports no problems; his blood pressure is well controlled on his current medication regimen; and his physical examination is unremarkable.
Jul 15, 2010 Issue
Screening and Treatment for Major Depressive Disorder in Children and Adolescents [Putting Prevention into Practice]
Case study: A woman brings her two children, a 14-year-old boy and a nine-year-old girl, to your office for a routine checkup. She tells you that her husband has major depression, and she wants to know whether her children should be checked for early signs of depression.
Jul 15, 2010 Issue
Screening and Treatment for Major Depressive Disorder in Children and Adolescents: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends screening adolescents (12 to 18 years of age) for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (i.e., cognitive behavioral or interpersonal), and follow-up.
Jul 1, 2010 Issue
Effectiveness of Antidepressants Compared with Placebo for Depression in Primary Care [Cochrane for Clinicians]
Tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) are more effective than placebo for the treatment of depression in primary care settings.